| 臺大學術典藏 |
2021-05-06T08:26:07Z |
Molecular detection and incidence of human papillomavirus in neonates: Methodology and a pilot study in a medical center
|
Tai C.-F.; Tsou T.-P.; Hsieh W.-S.; Chen C.-Y.; Chou H.-C.; Tsao P.-N.; Hsu C.-H.; Liau Y.-J.; Lu C.-Y.; PEI-LAN SHAO; Chang L.-Y.; Huang L.-M. |
| 臺大學術典藏 |
2021-05-05T03:17:40Z |
Computer-aided tumor detection in automated breast ultrasound using a 3-D convolutional neural network
|
Moon, W.K.; Huang, Y.-S.; Hsu, C.-H.; Chang Chien, T.-Y.; Chang, J.M.; Lee, S.H.; Huang, C.-S.; Chang, R.-F.; RUEY-FENG CHANG |
| 臺大學術典藏 |
2021-05-03T02:21:22Z |
P53 Overexpression predicts poor chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV colorectal cancers after palliative bowel resection
|
JIN-TUNG LIANG; Huang K.-C.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Chang K.-J. |
| 臺大學術典藏 |
2021-05-03T02:21:21Z |
High-frequency microsatellite instability predicts better chemosensitivity to high-dose 5-fluorouracil plus leucovorin chemotherapy for stage IV sporadic colorectal cancer after palliative bowel resection
|
JIN-TUNG LIANG; Huang K.-C.; Lai H.-S.; Lee P.-H.; Cheng Y.-M.; Hsu H.-C.; Cheng A.-L.; Hsu C.-H.; Yeh K.-H.; Wang S.-M.; Tang C.; Chang K.-J. |
| 臺大學術典藏 |
2021-05-02T03:29:22Z |
Incidence of chronic thromboembolic pulmonary hypertension in Taiwan
|
Liu H.-Y.; Lu T.-P.; Tao C.-W.; Wu Y.-J.; Huang W.-C.; Hsu C.-H.; Liao W.-C.; Hsu H.-H.; Lin M.-C.; CHONG-JEN YU |
| 臺大學術典藏 |
2021-04-27T08:36:01Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-04-27T08:36:01Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; HUNG-YANG KUO; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2021-04-27T08:35:59Z |
Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives
|
HUNG-YANG KUO; Guo J.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-04-27T08:11:51Z |
Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy
|
Guo J.-C.; Lin C.-C.; Huang T.-C.; Huang P.-M.; HUNG-YANG KUO; Chang C.-H.; Wang C.-C.; Cheng J.C.-H.; Yeh K.-H.; Hsu C.-H.; Lee J.-M. |
| 臺大學術典藏 |
2021-04-27T08:11:50Z |
Neutrophil-to-lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
|
Guo J.-C.; Lin C.-C.; Lin C.-Y.; Hsieh M.-S.; HUNG-YANG KUO; Lien M.-Y.; Shao Y.-Y.; Huang T.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-04-27T08:11:48Z |
Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives
|
HUNG-YANG KUO; Guo J.-C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-04-23T05:56:30Z |
Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours
|
De Bono J.;Lin C.-C.;Chen L.-T.;Corral J.;Michalarea V.;Rihawi K.;Ong M.;Lee J.-H.;Hsu C.-H.;Chih-Hsin Yang;Shiah H.-S.;Yen C.-J.;Anthoney A.;Jove M.;Buschke S.;Fuertig R.;Schmid U.;Goeldner R.-G.;Strelkowa N.;Huang D.C.-L.;Bogenrieder T.;Twelves C.;Cheng A.-L.; de Bono J.; Lin C.-C.; Chen L.-T.; Corral J.; Michalarea V.; Rihawi K.; Ong M.; Lee J.-H.; Hsu C.-H.; CHIH-HSIN YANG; Shiah H.-S.; Yen C.-J.; Anthoney A.; Jove M.; Buschke S.; Fuertig R.; Schmid U.; Goeldner R.-G.; Strelkowa N.; Huang D.C.-L.; Bogenrieder T.; Twelves C.; Cheng A.-L. |
| 臺大學術典藏 |
2021-04-20T03:45:59Z |
Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis
|
Lin Y.-J.;Wen C.-N.;Lin Y.-Y.;Hsieh W.-C.;Chang C.-C.;Chen Y.-H.;Hsu C.-H.;Shih Y.-J.;Chen C.-H.;Chi-Tai Fang; Lin Y.-J.; Wen C.-N.; Lin Y.-Y.; Hsieh W.-C.; Chang C.-C.; Chen Y.-H.; Hsu C.-H.; Shih Y.-J.; Chen C.-H.; CHI-TAI FANG |
| 臺大學術典藏 |
2021-04-08T01:25:44Z |
A voxel-based partial volume correction in nuclear medicine
|
HSUAN-MING HUANG; Hsiao I.-T.; Wietholt C.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-29T05:55:47Z |
Virtual Network Embedding with Dynamic Speed Switching Orchestration in Fog/Edge Network
|
Chiang, Y.; Chao, Y.-H.; Hsu, C.-H.; Chou, C.-T.; Wei, H.-Y.; CHUN-TING CHOU |
| 臺大學術典藏 |
2021-03-19T06:57:53Z |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin Z.-Z.; Hsu C.; YEUN-CHUNG CHANG; Yu C.-J.; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. |
| 臺大學術典藏 |
2021-03-19T01:54:21Z |
Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma
|
Shao Y.-Y.; TSUNG-HAO LIU; Lee Y.-H.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-19T01:54:20Z |
Considerations of heterogeneity in clinical trials for hepatocellular carcinoma
|
TSUNG-HAO LIU; Shao Y.-Y.; Lu L.-C.; Shen Y.-C.; Hsu C.; Lin Z.-Z.; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-19T01:54:20Z |
Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure
|
TSUNG-HAO LIU; Hsu C.-H.; Shao Y.-Y. |
| 臺大學術典藏 |
2021-03-19T01:54:20Z |
Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment
|
Lu L.-C.; Lee Y.-H.; Chang C.-J.; Shun C.-T.; Fang C.-Y.; Shao Y.-Y.; TSUNG-HAO LIU; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-19T01:54:19Z |
Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma
|
Shao Y.-Y.; TSUNG-HAO LIU; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-19T01:54:19Z |
Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
|
Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; TSUNG-HAO LIU; Hsu C.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2021-03-19T01:54:17Z |
It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade
|
TSUNG-HAO LIU; Shao Y.-Y.; Hsu C.-H. |
| 臺大學術典藏 |
2021-03-18T08:54:37Z |
Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma
|
Yen T.-J.; Chung C.-S.; YEN-WEN WU; Yen R.-F.; Cheng M.-F.; Lee J.-M.; Hsu C.-H.; Chang Y.-L.; Wang H.-P. |
| 臺大學術典藏 |
2021-03-18T08:54:23Z |
TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management
|
Wang C.-C.; Chang H.-Y.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J. |
